Citigroup
MOR

Citigroup’s MorphoSys AG American Depositary Shares MOR Stock Holding History

Citigroup’s Portfolio MOR Stock Details MOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,089
Closed -$38K – 5866
2024
Q2 		$38K Sell
2,089
-2,911
-58% -$52.9K ﹤0.01% 4737
2024
Q1 		$90.7K Buy
+5,000
New +$73.9K ﹤0.01% 4339

Other funds holding MOR

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup's MOR Position: Q3 2024 in Review

Citigroup sold out of MorphoSys AG American Depositary Shares (MOR) in Q3 2024, closing a stake of 2,089 shares — an estimated $38K sold.

Citigroup first reported a position in MOR in Q1 2024 and held it in 2 quarters. The position peaked at $90.7K in Q1 2024. 9 funds tracked by Wall St. Rank hold MOR as of Q3 2024.

  • Citigroup reported no remaining MorphoSys AG American Depositary Shares position as of Q3 2024 after selling out during the quarter.
  • Citigroup sold 2,089 MorphoSys AG American Depositary Shares shares in Q3 2024, an estimated $38K.
  • Citigroup first reported a position in MorphoSys AG American Depositary Shares in Q1 2024 and held it in 2 quarters.
  • Citigroup's MorphoSys AG American Depositary Shares position peaked at $90.7K in Q1 2024.
  • 9 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q3 2024.

Based on Citigroup's 13F filing for Q3 2024, filed 12 Nov 2024.